A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)
Clinical trial NCT05641324 · TERMINATED
Trial details
- NCT number
- NCT05641324
- Sponsor
- Anaveon AG
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-10
- Primary completion
- 2023-07-12
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.